This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 Dec 2010

FDA Sends Allergan Letter for 'Misleading' Lumigan Direct Mail

The FDA has posted on its web site a letter it sent to Allergan, Inc. for direct mail regarding the company's eye drug Lumigan.

Related News